These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38349383)

  • 1. A promising 'single' and 'dual' drug-nanocomposite enriched contact lens for the management of glaucoma in response to the tear fluid enzyme.
    Kumara BN; Velmurugan K; Ghate MV; Shambhu R; Nirmal J; Prasad KS
    J Mater Chem B; 2024 Feb; 12(9):2394-2412. PubMed ID: 38349383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma.
    Xu J; Ge Y; Bu R; Zhang A; Feng S; Wang J; Gou J; Yin T; He H; Zhang Y; Tang X
    J Control Release; 2019 Jul; 305():18-28. PubMed ID: 31103677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery.
    Maulvi FA; Lakdawala DH; Shaikh AA; Desai AR; Choksi HH; Vaidya RJ; Ranch KM; Koli AR; Vyas BA; Shah DO
    J Control Release; 2016 Mar; 226():47-56. PubMed ID: 26860285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained latanoprost release from PEGylated solid lipid nanoparticle-laden soft contact lens to treat glaucoma.
    Dang H; Dong C; Zhang L
    Pharm Dev Technol; 2022 Feb; 27(2):127-133. PubMed ID: 34704874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of benzalkonium chloride in topical glaucoma treatment: An investigation of the efficacy and safety of benzalkonium chloride-preserved intraocular pressure-lowering eye drops and their effect on conjunctival goblet cells.
    Nagstrup AH
    Acta Ophthalmol; 2023 Dec; 101 Suppl 278():3-21. PubMed ID: 38037546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual drug delivery from vitamin E loaded contact lenses for glaucoma therapy.
    Hsu KH; Carbia BE; Plummer C; Chauhan A
    Eur J Pharm Biopharm; 2015 Aug; 94():312-21. PubMed ID: 26071799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of Latanoprostene Bunod, Timolol Maleate, and latanoprost Ophthalmic Solutions to assess their safety and efficacy in lowering intraocular pressure for the management of Open-Angle Glaucoma.
    Wang Y; Liao Y; Nie X
    Clinics (Sao Paulo); 2020; 75():e1874. PubMed ID: 33263632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latanoprost-Eluting Contact Lenses in Glaucomatous Monkeys.
    Ciolino JB; Ross AE; Tulsan R; Watts AC; Wang RF; Zurakowski D; Serle JB; Kohane DS
    Ophthalmology; 2016 Oct; 123(10):2085-92. PubMed ID: 27586444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of self-assembling system and N,O-carboxymethyl chitosan improves ocular residence of anti-glaucoma drug.
    Kailasam V; Kumara BN; Prasad KS; Nirmal J
    Eur J Pharm Biopharm; 2024 Apr; 197():114208. PubMed ID: 38336235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermosensitive chitosan-gelatin-based hydrogel containing curcumin-loaded nanoparticles and latanoprost as a dual-drug delivery system for glaucoma treatment.
    Cheng YH; Ko YC; Chang YF; Huang SH; Liu CJ
    Exp Eye Res; 2019 Feb; 179():179-187. PubMed ID: 30471279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of timolol and hyaluronic acid from semi-circular ring-implanted contact lenses for the treatment of glaucoma: in vitro and in vivo evaluation.
    Desai AR; Maulvi FA; Pandya MM; Ranch KM; Vyas BA; Shah SA; Shah DO
    Biomater Sci; 2018 May; 6(6):1580-1591. PubMed ID: 29708242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-delivery of Brinzolamide and Timolol from Micelles-laden Contact Lenses: In vitro and In Vivo Evaluation.
    Yang H; Zhang F; Fan Y; Zhang J; Fang T; Xing D; Zhen Y; Nie Z; Liu Y; Wang D; Li J
    Pharm Res; 2024 Mar; 41(3):531-546. PubMed ID: 38366235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: In vitro and in vivo evaluation.
    Maulvi FA; Patil RJ; Desai AR; Shukla MR; Vaidya RJ; Ranch KM; Vyas BA; Shah SA; Shah DO
    Acta Biomater; 2019 Mar; 86():350-362. PubMed ID: 30625414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug delivery by contact lens in spontaneously glaucomatous dogs.
    Peng CC; Ben-Shlomo A; Mackay EO; Plummer CE; Chauhan A
    Curr Eye Res; 2012 Mar; 37(3):204-11. PubMed ID: 22335807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A triple crosslinked micelle-hydrogel lacrimal implant for localized and prolonged therapy of glaucoma.
    Zhao J; Xiong J; Ning Y; Zhao J; Wang Z; Long L; He H; Gou J; Yin T; Tang X; Zhang Y
    Eur J Pharm Biopharm; 2023 Apr; 185():44-54. PubMed ID: 36841507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of pilocarpine, timolol and latanoprost in experimental models of glaucoma.
    Gupta SK; Agarwal R; Galpalli ND; Srivastava S; Agrawal SS; Saxena R
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):665-71. PubMed ID: 18200329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mucoadhesive chitosan film for ophthalmic drug delivery of timolol maleate: in vivo evaluation.
    Fulgêncio Gde O; Viana FA; Ribeiro RR; Yoshida MI; Faraco AG; Cunha-Júnior Ada S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):350-8. PubMed ID: 22320419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan nanoparticles laden contact lenses for enzyme-triggered controlled delivery of timolol maleate: A promising strategy for managing glaucoma.
    Maulvi FA; Patel AR; Shetty KH; Desai DT; Shah DO; Willcox MDP
    Drug Deliv Transl Res; 2024 Feb; ():. PubMed ID: 38407770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed-Dose Combination of Netarsudil and Latanoprost in Ocular Hypertension and Open-Angle Glaucoma: Pooled Efficacy/Safety Analysis of Phase 3 MERCURY-1 and -2.
    Asrani S; Bacharach J; Holland E; McKee H; Sheng H; Lewis RA; Kopczynski CC; Heah T
    Adv Ther; 2020 Apr; 37(4):1620-1631. PubMed ID: 32166538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.